Comparison between Jain International Power IPO and Rednex Pharmaceuticals IPO.
Jain International Power IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Rednex Pharmaceuticals IPO is a SME Bookbuilding proposed to list at BSE SME.
The total issue size of Jain International Power IPO is up to ₹70.00 Cr whereas the issue size of the Rednex Pharmaceuticals IPO is up to ₹0.00 Cr. The final issue price of Jain International Power IPO is and of Rednex Pharmaceuticals IPO is .
| Jain International Power IPO | Rednex Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 27,36,000 shares |
| Fresh Issue Size (Amount) | up to ₹70.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 27,36,000 shares |
| Issue Size Total (Amount) | up to ₹70.00 Cr | up to ₹0.00 Cr |
Jain International Power IPO opens on , while Rednex Pharmaceuticals IPO opens on . The closing date of Jain International Power IPO and Rednex Pharmaceuticals IPO is , and , respectively.
Jain International Power IPO P/E ratio is , as compared to Rednex Pharmaceuticals IPO P/E ratio of .
| Jain International Power IPO | Rednex Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Standalone)Jain International Power Ltd.'s revenue increased by 195% and profit after tax (PAT) rose by 349% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Rednex Pharmaceuticals Ltd.'s revenue increased by 88% and profit after tax (PAT) rose by 120% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 78.74 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 88.00 | 58.10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 72.49 | 23.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.46 | 2.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 88.00 | 45.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Jain International Power IPO Retail Individual Investors (RII) are offered 0 shares while in Rednex Pharmaceuticals IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Jain International Power IPO and 0 shares in Rednex Pharmaceuticals IPO.
| Jain International Power IPO | Rednex Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Jain International Power IPO subscribed in total, whereas Rednex Pharmaceuticals IPO subscribed .
